Physician profile
Kelley Hill
NPI 1063852473
$6,101.67
in general payments reported to CMS, 2019-2025
16 companies · $5,968 in 2025
The $5,968 reported for 2025 was more than what 89% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $134 · 2025: $5,968.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,000 · Food and Beverage: $1,298 · Travel and Lodging: $804.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,000.00 |
| Food and Beverage | $1,298.02 |
| Travel and Lodging | $803.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,979.52 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $148.44 | 2025 | Dupixent |
| Glaxosmithkline, LLC. | $147.01 | 2025 | Nucala, Trelegy Ellipta |
| Genzyme Corporation | $139.63 | 2025 | |
| Abiomed | $117.92 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $100.00 | 2023 | Lifevest |
| Viatris Specialty LLC | $78.67 | 2025 | Yupelri |
| Astrazeneca Pharmaceuticals LP | $68.07 | 2025 | Airsupra, Tezspire |
| Boehringer Ingelheim Pharmaceuticals, INC. | $63.82 | 2025 | Jascayd |
| Insmed, INC. | $60.67 | 2025 | Brinsupri, Arikayce |
| Verona Pharma, INC. | $48.51 | 2025 | Ohtuvayre |
| Harmony Biosciences LLC | $37.35 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $34.71 | 2025 | Glassia |
| Bayer Healthcare Pharmaceuticals INC. | $33.55 | 2023 | |
| Merck Sharp & Dohme LLC | $28.63 | 2025 | Zerbaxa |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $15.17 | 2025 | Uptravi, Opsynvi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelley Hill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.